In adults with metabolic dysfunction, the MAF-5 score predicted risk for liver fibrosis (AUC range, 0.73 to 0.81).
Where this comes from
- Record sourced from PubMed, PMID 39348699.
- Also identified by DOI 10.7326/ANNALS-24-02090-JC.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
van Kleef LA, Francque SM, Prieto-Ortiz JE, et al. <b>Metabolic Dysfunction-Associated Fibrosis 5 (MAF-5) score predicts liver fibrosis risk and outcome in the general population with metabolic dysfunction.</b> Gastroenterology. 2024;167:357-367.e9. 38513745.